-+ 0.00%
-+ 0.00%
-+ 0.00%

IMMUNITYBIO - SUPPLEMENTAL BLA FOR ANKTIVA ON TRACK FOR FDA SUBMISSION BY YEAR-END 2026

Reuters·11/09/2026 11:30:01

Please log in to view news